Bayerische Motoren Werke ADR (BMWYY)

Nutriband (NASDAQ: NTRB) is reminding shareholders of its upcoming 25% preferred stock dividend. Shareholders of record as of July 25, 2025, will receive one preferred share for every four common shares held, with the dividend payable on August 5. Each preferred share will be convertible to one common share upon FDA approval of Nutriband’s AVERSA Fentanyl product. Unconverted preferred shares will be eligible for annual cash dividends from company profits at the discretion of the board.

A new study has found that individuals who are later diagnosed with multiple sclerosis (MS) tend to visit their doctor more, are admitted to hospitals more, and visit emergency rooms more frequently decades before they are eventually diagnosed with MS in comparison to those who don’t develop the condition . This often happens more than 20 years before an MS diagnosis is made.

Soligenix (NASDAQ: SNGX) is reporting encouraging interim outcomes from the ongoing investigator-initiated study (“IIS”) of its HyBryte(TM) (synthetic hypericin) program, under the direction of Ellen Kim, MD, director of the Penn Cutaneous Lymphoma Program. Kim is a leading enroller in Soligenix’s phase 3 FLASH study and serves as principal investigator for the confirmatory phase 3 FLASH2 trial, which recent data from the IIS indicates is delivering promising treatment success in early-stage cutaneous T-cell lymphoma (“CTCL”).

The results of the 2025 American Consumer Awards in the ‘Automotive' category, organized by the American Consumer Right Association and managed by the American Consumer Assessment, have been announced for the New York region.

Lung cancer, one of the most common types of cancer, has for a long time been known to largely develop among smokers. However, recent studies have established that around one quarter of people diagnosed with lung cancer has never smoked. This has baffled the scientific community as there was no clear explanation why such a significant proportion of lung cancer patients didn’t have a history of smoking.

Recent polling by KFF has provided insights into the numerous challenges that Americans face in meeting their health care costs. The poll, conducted in May and whose findings were published in June this year, shows that one of the major worries that American families face is having unexpected medical bills to pay.

Spotlight Diagnostics, a startup based in Eindhoven, Netherlands, is developing a test kit that will enable personnel to rapidly test for infectious diseases without requiring lab facilities . The kit targets infectious diseases like malaria, Chlamydia, gonorrhea and others that take a huge toll on human life.

Las Vegas, Nevada - July 10, 2025 - The retrofittable SmartTOP roof top module for the Ferrari Portofino M is now available. The latest development from Mods4cars makes everyday convertible use easier thanks to intelligent additional functions.“In addition to the Ferrari 360, F430 Spider, 458/488 Spider, California, F8, 296 GTS, and Portofino, we can now offer a convenient solution for the Ferrari Portofino M as well,” says PR spokesperson Sven Tornow.

Libertyville, IL () July 10, 2025 -- Auto Lab Libertyville expands into full-spectrum BMW maintenance, expertly addressing car owners’ issues and concerns.

A new study that has been published in JAMA Network has found that military veterans that sustained traumatic brain injuries (TBIs) had an elevated risk of developing cancerous brain tumors. Doctor Ian Stewart, who led this breakthrough study, explains that his team found that veterans that sustained moderate or severe TBIs had their likelihood of developing brain cancer increase by 90%.

Luxury San Francisco-based limo company Limo SF VIP (888 888-0195) announces private chauffeured transportation services to and from major and smaller airports throughout the Bay Area.

Brighton and Hove, Brighton () July 8, 2025 -- Bike Buyer UK makes it easier than ever to get a fast, fair, and free valuation for motorcycles with no pressure to sell.

University of Sydney researchers have, for the first time ever, targeted a malfunctioning protein in mice having symptoms akin to Parkinson’s symptoms and successfully improved motor function in the mice. This breakthrough finding could open the door to finding a similar way to treat Parkinson’s disease in humans.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly-owned subsidiary HOPE Therapeutics, Inc., a multi-site clinical care delivery organization, recently signed a binding letter of intent to acquire a 49% stake in Cohen and Associates, LLC, a respected neuropsychiatry clinic based in western Florida ( https://ibn.fm/geIxF ).

GMV Car Parts (+447367808606) has increased its workforce to strengthen service delivery for tyre pressure monitoring systems (TPMS) and essential automotive components across the UK.

Rob Bonta, the Attorney General of California, revealed on Tuesday that 20 states have filed a lawsuit challenging the federal government’s release of private Medicaid data to deportation personnel in June. The shared data affects millions of people enrolled in Medicaid.

Mainz, Germany, July 5, 2025 -- As the global shift toward electric mobility accelerates, BTR New Material Group showcased at the 15th Advanced Automotive Battery Conference (AABC) Europe to present its cutting-edge materials roadmap for next-generation batteries.

The opioid crisis remains one of the most pressing public health challenges of our time. While synthetic opioids like fentanyl play a crucial role in managing severe pain, their high abuse potential has led to a growing demand for smarter, safer delivery systems. As policymakers, healthcare providers, and regulators seek solutions that balance medical necessity with public safety, innovative technologies are emerging that could reshape how these powerful drugs are administered.

While studying why non-human primates aren’t as likely to suffer from certain cancers when compared to humans, UC Davis scientists discovered a genetic mutation that could explain this anomaly. Their findings were published in the Nature Communications journal. This discovery could open the door to the development of more powerful treatments for cancer.

In a recent webinar hosted by Allele Capital, Soligenix (NASDAQ: SNGX) executives Dr. Christopher Schaber and Dr. Christopher Pullion shared detailed updates on the company’s HyBryte(TM) (synthetic hypericin) clinical development ( https://ibn.fm/dz7eO ). The event offered an in-depth look at Soligenix’s ongoing confirmatory phase 3 trial for cutaneous T-cell lymphoma (“CTCL”), a rare non-Hodgkin’s lymphoma, and discussed promising data emerging from an investigator-initiated study conducted at the University of Pennsylvania. Soligenix, a late-stage biopharmaceutical company, is dedicated to developing and commercializing treatments for rare diseases and unmet medical needs, and HyBryte(TM) represents the company’s lead asset aimed at transforming the treatment landscape for CTCL.

Oragenics (NYSE American: OGEN) a developer of intranasal pharmaceuticals for neurological disorders, has entered into a placement agency agreement for the sale of up to 800,000 shares of Series H Convertible Preferred Stock and accompanying Warrants, priced at $25.00 per unit. Each Warrant allows purchase of an additional Preferred share at $25.00, with Preferred shares convertible into common stock at $2.50. Gross proceeds could total $20 million, which will support ONP-2 concussion trials, R&D, repayment of a $3 million bridge note, and general corporate needs. Dawson James Securities, Inc. is acting as sole placement agent, with closing expected on or about July 2, 2025.

Existing scientific information shows that pesticides are toxic to the microorganisms in the gut, and a new preclinical study has mapped the specific impacts that compounds in pesticides have on microbes in the human digestive system. One surprising finding emerged regarding how these pesticide compounds affect the inflammatory system in the body.

Nutriband (NASDAQ: NTRB) has been added to the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes as part of the 2025 Russell indexes reconstitution. CEO Gareth Sheridan called the inclusion a reflection of market recognition and momentum behind the company’s AVERSA pipeline, particularly AVERSA Fentanyl, which has potential peak annual U.S. sales between $80 million and $200 million. Russell indexes, maintained by FTSE Russell, benchmark approximately $10.6 trillion in assets and are widely used by investment managers and institutions.

NextPlat (NASDAQ: NXPL, NXPLW) released a shareholder letter from Interim CEO expressing confidence in the company’s future following the recent passing of CEO and Chairman Charles M. Fernandez. The letter highlights internal reviews, meetings with subsidiary leaders, and plans for increased focus, coordination, and strategic investment to build on the company’s existing foundation and drive long-term value creation.

Panda Hub announces expansion across 15 U.S. states and 2 Canadian provinces, offering mobile car detailing services with certified professionals and sustainable practices.